Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors-Reference-Cited by-同舟云学术

Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors

Published:2022-10-01 Issue:8 Volume:35 Page:545-552
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Phakaratsakul Supinya¹,Manopwisedjaroen Suwimon²,Boonarkart Chompunuch¹,Kupatawintu Pawinee³,Chaiwanichsiri Dootchai³,Roytrakul Thaneeya⁴⁵,Auewarakul Prasert¹,Thitithanyanont Arunee²^ORCID

Affiliation:

1. Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

2. Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand.

3. National Blood Centre, Thai Red Cross Society, Bangkok, Thailand.

4. Medical Biotechnology Research Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Bangkok, Thailand.

5. Dengue Hemorrhagic Fever Research Unit, Office of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2022.0059

Reference27 articles.

1. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

2. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

3. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

4. Neutralizing antibodies for the prevention and treatment of COVID-19

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Disorders: Response and Achille Heel in the Framework of SARS-Cov-2- a Short Review;Comprehensive Hematology and Stem Cell Research;2024

2. Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis;Frontiers in Immunology;2023-06-19

3. Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus;Viruses;2023-02-11

4. Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma;Nature Cancer;2022-12-21